H-1B sponsorship profile: Sage Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Sage Therapeutics, Inc filed 23 Labor Condition Applications covering 23 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 82.6% (19 certified of 23 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Sage Therapeutics, Inc’s H-1B petitions range from $135,000 at the low end to $240,240 at the high end, with a petition-weighted average of $172,999. That range reflects the mix of occupations the company sponsors, led by Senior Manager, Pharmacovigilance Operations (4 petitions at $153,377 avg), followed by Associate Director, HEOR, Real World Evidence and Senior Manager, Pharmacovigilance Operations. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Sage Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 6 states, most heavily in MA, VA, FL. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Sage Therapeutics, Inc ranks. By H-1B petition volume, Sage Therapeutics, Inc is #9,127 of 119,880 employers nationally and #391 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.